0001171843-23-007278.txt : 20231127 0001171843-23-007278.hdr.sgml : 20231127 20231127113111 ACCESSION NUMBER: 0001171843-23-007278 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20231127 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231127 DATE AS OF CHANGE: 20231127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 231438880 BUSINESS ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-206-8220 MAIL ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 f8k_112723.htm FORM 8-K Form 8-K
0000806517 False 0000806517 2023-11-27 2023-11-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 27, 2023

_______________________________

PSYCHEMEDICS CORPORATION

(Exact name of registrant as specified in its charter)

_______________________________

Delaware1-1373858-1701987
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

289 Great Road

Acton, Massachusetts 01720

(Address of Principal Executive Offices) (Zip Code)

(978) 206-8220

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock. $0.005 par valuePMDThe NASDAQ Stock Market, LLC.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

       (c)        On November 27, 2023, the Psychemedics Corporation (the “Company”) appointed Daniella Mehalik as Vice President – Finance and as Treasurer of the Company.  In such capacity Ms. Mehalik, age 33, will serve as the Company’s principal financial and accounting officer and will be responsible for all internal and external financial reporting activities, as well as the Company’s financial analysis and planning activities.  She will report directly to the CEO.  Ms. Mehalik has over 10 years of finance and accounting experience.  Most recently, since 2021, she served as Controller at NeuBase Therapeutics, Inc. (Nasdaq: NBSE), a genetic medicine platform company. From 2019 to 2021 she served as Controller for DxTx Medical Inc., of Pittsburgh, Pennsylvania, a medical device manufacturer of specialized accessories for medical radiology applications. From 2018 to 2019 she served as Audit Team Leader at Arconic Corporation (NYSE: ARNC), an industrial company specializing in lightweight metals engineering and manufacturing.  Prior to her controllership roles in the biotechnology and medical device industries, she spent several years in private and public accounting focusing on manufacturing and industrial engineering industries. She received a Bachelor’s degree in Business, Accounting, and Forensic accounting from Carlow University and a Master of Science Degree in Fraud and Forensic Accounting from Carlow University.

       (e)        In connection with Ms. Mehalik’s appointment, the Company and Ms. Mehalik have entered into a written employment agreement (the “Employment Agreement”) pursuant to which Ms. Mehalik will serve as an at-will employee with the following compensation terms: (a)  a base salary of $205,000; (b) an annual bonus target of 25% of base salary, with the annual bonus for 2024 of not less than 10% of base salary ($20,500) to be guaranteed, subject to certain conditions; and (c) a signing bonus of $10,000, subject to certain conditions.

       The foregoing description of the Employment Agreement with Ms. Mehalik is a summary and is qualified in its entirety by reference to the Employment Agreement, which is attached hereto as Exhibit 10.1 and is incorporated by reference herein.

Item 7.01. Regulation FD Disclosure.

       The Company issued a press release on November 27, 2023 announcing the hiring of Ms. Mehalik. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. 

       Limitation on Incorporation by Reference. The information furnished in this Item 7.01, including the presentation attached hereto as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number Description
   
10.1 Employment Agreement with Daniella Mehalik dated November 27, 2023  
99.1 Press Release dated November 27, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 PSYCHEMEDICS CORPORATION
   
  
Date: November 27, 2023By: /s/ Brian Hullinger        
  Brian Hullinger
  President and Chief Executive Officer
  

 

 EX-10.1 2 exh_101.htm EXHIBIT 10.1 EdgarFiling

Exhibit 10.1

 

 

 

November 27, 2023

 

 

Daniella Mehalik
Pittsburgh, PA



 

Dear Daniella,

On behalf of Psychemedics Corporation (“Psychemedics” or the “Company”), I am pleased to extend a formal offer of employment to you with the Company. This offer letter agreement (the “Agreement”) provides the terms and conditions of your employment with the Company. Your tentative start date is November 27, 2023.

 

1. Position: Your position with Psychemedics will be Vice President of Finance (“VP of Finance”), reporting to the Chief Executive Officer (“CEO”). While serving as the VP of Finance, you will perform the standard and customary duties and responsibilities of the VP of Finance role, as well as any other duties and responsibilities as reasonably assigned to you by the CEO. Psychemedics and you acknowledge and agree that you will be based at your home office located in Pennsylvania and will travel as may be necessary to fulfill your responsibilities.

 

2. Compensation:

a. Your base salary will be at an annualized rate of $205,000.00 per year (the “Base Salary”), payable in substantially equal periodic installments in accordance with the Company’s payroll practices.

b. Your annual bonus target is set at $51,250.00 (25% of your base salary) and your first annual bonus review will take place in the first quarter of 2025 (for calendar year 2024). You will be eligible for the annual cash bonus subject to your being an employee in good standing on the date of any applicable bonus payment. The bonus for calendar year 2024 will be determined at the Board’s sole discretion, which generally will be based on Company results as well as individual performance but will be guaranteed to pay a minimum of $20,500 (10% of your base salary) provided you are not terminated for Cause1 or do not resign without Good Reason2 prior to December 31, 2024.

 

289 great rd, suite 200, acton, ma 01720

Tel: 978-206-8220, fax: 978-264-9236

WWW.psychemedics.COM

 

 

c. We are also pleased to offer you a one-time, sign-on bonus of $10,000.00 to held defray your transition costs from your current employer (the “Sign-On Bonus”). The Sign-On Bonus will be paid with regular payroll on January 18th, 2024, provided that you are an employee in good standing on the date of payment. If you voluntarily terminate your employment with the Company for any reason or if the Company involuntarily terminates your employment for Cause3 in either event within twelve (12) months of your Start Date, then (i) you will repay to the company the entire amount of the Sign-On Bonus (if paid) and (ii) you authorize the Company to deduct and/or offset the amount of such Sign-On Bonus from any amounts otherwise due from the Company to you, to the extent permitted by law.

d. You and your dependents are eligible for coverage under the Company’s health package, subject to plan terms and conditions. You are also eligible to participate in benefit programs made available to all employees and will be eligible to enroll in our Company sponsored 401(k) Plan. Your eligibility for benefits will be subject to eligibility requirements, conditions, terms and restrictions in any applicable plan or policy document. The Company retains the right to change, add or cease any particular benefit.

 

 

1 For purposes of this Agreement, “Cause” will mean (i) theft or embezzlement, or attempted theft or embezzlement, by you of money or property of the Company, your perpetration or attempted perpetration of fraud, or your participation in a fraud or attempted fraud upon the Company; (ii) your unauthorized appropriation of, or attempt to misappropriate, any tangible or intangible assets or property of the Company, or your appropriation of, or attempt to appropriate, a business opportunity of the Company, including but not limited to attempting to secure or securing any profit for yourself or any of your family members or personal associates in connection with any transaction entered into on behalf of the Company; (iii) any act or acts of disloyalty, misconduct, or moral turpitude by you, including but not limited to violation of the Company’s sexual harassment or non-harassment policy, any of which the Board determines in good faith has been or is likely to be materially injurious to the interest, property, operations, business, or reputation of the Company, or its directors, employees or shareholders; (iv) any act or omission constituting gross negligence in connection with the performance of your duties on behalf of the Company which is materially injurious to the interest, property, operations, business, or reputation of the Company; (v) your conviction of a crime other than minor traffic violations or other similar minor offenses (including pleading guilty or entering a plea of no contest), or your indictment for a felony or its equivalent, or your being charged with a violent crime, a crime involving moral turpitude, or any other crime for which imprisonment is a possible punishment; (vi) your willful refusal or material failure to carry out reasonable and lawful instructions and directives from the Board and your failure to cure or correct such refusal or failure within ten (10) days after receiving written notice from the Board describing such refusal or failure; or (vii) the material breach by you of your obligations under any confidentiality, non-compete, non- solicitation, non-disparagement or similar agreement with the Company.



2 For purposes of this Agreement, “Resignation for Good Reason” will be deemed to occur in the event: (i) any of the following bases (a)-(c) occur; (ii) you provide written notice of termination to the Company within thirty (30) days thereafter, specifying the basis for your resignation; (iii) the Company does not cure such basis within thirty (30) days after receipt of such notice, and (iv) you terminate your employment within thirty (30) days following the end of such cure period: (a) the Company materially diminishes your duties and responsibilities without Cause; (b) the Company materially reduces your base salary (other than in connection with a Company-wide decrease in salary); or (c) the Company materially breaches any of its obligations to you pursuant to this Agreement.

 

 

289 great rd, suite 200, acton, ma 01720

Tel: 978-206-8220, fax: 978-264-9236

WWW.psychemedics.COM

 2 

 

e. You will be entitled to reimbursement for all ordinary and reasonable out-of-pocket business expenses that are reasonable incurred by you in the furtherance of the Company’s business, following submission of reasonably detailed receipts and otherwise subject to the terms and conditions of any applicable Company policy or rules.

 

3. At-Will Employment: Employment at the Company is at-will. We recognize that you retain the option, as does the Company, of ending your employment with the Company at any time, with or without notice and with or without Cause. We are a dynamic organization in a rapidly changing industry. The responsibilities associated with your job may change from time to time in accordance with the Company’s business needs. You may be required to perform additional and/or different responsibilities.

4. Devotion of Time and Efforts: While you render services to the Company, you will not assist (including to mean, without limitation, investing in, consulting for, serving as an employee or director, or otherwise advising) any person or organization, public or private, in competing with the Company, in preparing to compete with the Company, or in hiring any employees away from the Company. As an employee of the Company, you are expected to make or participate in business decisions and actions in the course of your employment based solely on the best interests of the Company as a whole, and without consideration of personal relationships or benefits. While you render services to the Company, you will not engage in any other gainful employment, business, or activity without written consent of the Company. You may, with consent, participate in financial, business and other activities outside the scope of your employment so long as the activities do not conflict with your responsibilities to the Company.

5. Certifications: Your employment is contingent upon the satisfactory completion of background screening, drug testing, and verification of authorization to work in the United States. By signing this Agreement, you are certifying that: (a) your employment with the Company does not violate any order, judgment or injunction, and (b) all facts presented to the Company are accurate and true, including those pertaining to education, qualifications, licensing. You may not disclose any confidential information belonging to a previous employer to the Company or use or incorporate the proprietary information of a previous employer into Company inventions or developments, and you agree to abide by any contractual obligation to prior employers.

 

289 great rd, suite 200, acton, ma 01720

Tel: 978-206-8220, fax: 978-264-9236

WWW.psychemedics.COM

 3 

 

6. Covenants Agreement: The Company considers the protection of its confidential information, proprietary materials and goodwill to be extremely important. Accordingly, as an express condition of employment, you will be required to execute and abide by the Company’s standard Confidentiality, Inventions, Non-Competition, and Non-Disclosure Agreement.

 

7. Section 409A: The parties intend that this Agreement will be administered in accordance with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”). To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision will be read in such a manner so that all payments hereunder comply with Section 409A of the Code. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). Anything in this Agreement to the contrary notwithstanding, if at the time of your separation from service within the meaning of Section 409A of the Code the Company determines that you are a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this Agreement on account of your separation from service would be considered deferred compensation otherwise subject to the twenty percent (20%) additional tax imposed pursuant to Section 409A(a) of the Code, such payment will not be payable and such benefit will not be provided until the date that is the earlier of (A) six (6) months and one (1) day after your separation from service, or (B) your death. All in-kind benefits provided and expenses eligible for reimbursement under this Agreement will be provided by the Company or incurred by you during the time periods set forth in this Agreement. All reimbursements will be paid as soon as administratively practicable, but in no event will any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one (1) taxable year will not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon your termination of employment, then such payments or benefits will be payable only upon your “separation from service.”

 

8. General: This Agreement and any documents referenced herein contain all the terms of your employment with the Company, and supersede any other agreements, documents or conversations (written or verbal) about such terms. The terms of this Agreement may be amended only by written agreement executed by the parties, and a term may be waived only by a written document executed by the party entitled to the benefits of such term. The Company may assign its rights and obligations hereunder to any person or entity that succeeds to all or substantially all of the Company’s business. You may not assign your rights and obligations hereunder without the prior written consent of the Company. This Agreement will be governed by the internal law of Delaware, without giving effect to the conflict of law principles thereof. The parties agree that any legal action in connection with this Agreement and/or your employment with the Company will be brought in Delaware state or federal court.

 

 

289 great rd, suite 200, acton, ma 01720

Tel: 978-206-8220, fax: 978-264-9236

WWW.psychemedics.COM

 4 

 

Please confirm your acceptance of this Agreement by signing and dating where indicated below. The terms of this offer expire in 5 calendar days. Please return a copy of this Agreement by mail or a PDF email to the CEO.

 

If you need further information regarding this offer or any other aspect of employment at the Company, feel free to reach out to Brian Hullinger. We are delighted you will be joining us and to your becoming part of the Psychemedics team.


PSYCHEMEDICS CORPORATION

 





By:    /s/ Brian Hullinger                                 
       Brian Hullinger, Chief Executive Officer


          November 27, 2023                                
Date

 

 

 

ACCEPTED AND AGREED:

 

 

 

/s/ Daniella Mehalik                                        
Signature


      Daniella Mehalik                                       
Printed Name


      November 27, 2023                                   
Date

 

 

 

 

289 great rd, suite 200, acton, ma 01720

Tel: 978-206-8220, fax: 978-264-9236

WWW.psychemedics.COM

5 

 

 

 EX-99.1 3 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

logo

Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as its new Vice President - Finance.

In her new role, Ms. Mehalik will assume responsibility for directing and managing all financial activities at Psychemedics, including comprehensive oversight of external reporting and internal analysis. Reporting directly to CEO and President Brian Hullinger, she will play a pivotal role in steering the financial trajectory of the organization.

Bringing over a decade of extensive experience to her new position, Ms. Mehalik possesses a robust background in accounting, honed through tenures at esteemed public accounting firms. Her most recent position as Vice President and Controller at Neubase Therapeutics, Inc. (NASDAQ: NBSE) in Pittsburgh, PA, provides her with industry-specific insights crucial to Psychemedics’ operations.

Ms. Mehalik's academic credentials include both undergraduate and master’s degrees in accounting from Carlow University in Pittsburgh, further underscoring her dedication to the field.

Commenting on this appointment, Mr. Hullinger stated, "We are thrilled to welcome Daniella to our team, entrusting her with a critical role in the company. Her strong technical background within the biotech sector aligns seamlessly with Psychemedics' growth strategy, positioning the company for sustained advancement.”

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing. For more information about Psychemedics Corporation and its innovative hair testing solutions, please visit www.psychemedics.com.

Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com

 GRAPHIC 4 logo.jpg begin 644 logo.jpg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Ζ.?9:!G0Z#K46OZ M9%>PHT:2$C:W7@X_I5N\N5L[6:=@2L:%R!UX&:YSX9_\B?:?[TG_ *&:V]<_ MY M__P!<'_\ 030!S#_%3339^;!;SW$XSO@3&4 [D]*W/#/BJR\4VC36I*NF M-\3_ 'ES_3_"N:^$4$7]BWKA%WM.0S8Y(VC@U1^'(B7QAK:VO_'OE^G3[_% MCTRN;U_QU8Z'=BS6.2\O?^>,.,CV)/?VKI*\>\-PZO<>--7-M<6MOJ(9\FXC MW$C?SC]*!GH/ASQI9>(II+9%DMKR,9:WEQG'L1^'YUT%<)I_@_5?^$NMM7O[ MVU>9!\ZP+M+C:1R._6N[I <[KGCC3_#VK)8W@="T/G>8!D?Q8&/4[3^8I_A/ MQ?!XMCNG@MY(!;N$/F$'.<^GTKE/%MC#J/Q1T:"X3S(FA0E3T.#(<'VR*]&B MAC@4B.-8P>RJ!3 AU.&&XTVZCN$\R!HF#KZKCD5S/PU72_[.NWTN*:)6E D\ MY@22!D8QQC!KI]2_Y!]U_P!0Q_?VG;]<<5YS\(4B>;5)9@O]H97?G[P! M+9_I0!UGAOQG8>)F>. M#EPV\5NN(HTC'HB@4 24444@$KQOP M1H5IX@\6:W#>J\D<9=E"N5P?,([5[)7AWAKP[+XB\2Z]%!>26MUY1\+_LECX@O+/4( M=NLJ2LLK2OB)9 M7U]':7-M-ITTI C\_&&STY!XS7*>.%NY?B-I\<,J1-A/+:X&8QZ<'CKFM76O M!_B+7FMS>ZE9 PMF-DCVG)_#]* /0JR/$?B:R\,6JS7;,2YPD:#YF/\ G^=: ML:LL:ACN8 GUKE?'WA&X\306TMG,L5W;$E0W1LD'\#D4AC]$\?6VKZA%926 M=Q97$P)C60 A@!GMTKJ:\^T'QCJEIXA@T?7K-!<2?+'<*H!YS@\<$'':O0:8 M&%J/BRWTWQ%9Z1)%(TUR%*NN-HR6'/\ WR:;XI\86WA4VPN(9)?/W8V8XQC/ M7ZUROBQ@OQ4T$DX&R,?^/25%\9R/,T<9YS+_ "6@1Z=7"?%[_D V?_7TO\C7 M=UPGQ>_Y -G_ -?2_P C0AG5^'_^0#IO_7M%_P"@"J_BG7DT'2Y)729V=65# M$N=K;202>PJQX?\ ^0#IO_7M%_Z */$'_("U#_K@_P#Z":0'#_#?Q@)K=;*6 M*XFEDFP)F(( P ,]_P#.:](KB_A4!_PC)&GCCAFM[B$ R12@<9Z(4UW1I M5-RHR8GQU"[>,\'( _6K?@CQC/K5]=Z??VBVVHPC+L@QNP<'([$&@1V5%%1K M<122/&LB-(GWD# E?J*0R2OC#]J[_DK:_P#7E!_-J^SZ^,/VKO\ DK:_]>4' M\VKZWAC_ '__ +=?Z'Y_QQ_R*?\ MY?J?#_[)=' MO-$U.$D-;WD11NI&5[,N0<,,@]C6%7[]?%+X,^#?C1H+:3XPT*VU>V_Y9R.- MLT)]8Y!AD/T-?G5^T%_P3#\3>#_M6K_#:[;Q3I*Y. MA-?587-:5;W:GNO\#-Q9XE\ _P!M#XC? &6&UT[4O[9\.JWSZ+J9,D('?RSG M=&?]TXXY!KO/CY_P4:^('Q9AFTOPXO\ PA&@2KL>.RF+W4P(Y#S8! //"@<= MWC+R2,> JJ M.23Z"OIO]GS_ ()]_$/XT&VU/5X&\&^%Y,/]LU",_:)EY_U4/!/3[S;1R"-U M?I7\"_V3_AW^S]:HWAW2%N-8*[9=:O\ $MU)TSAB,(#C[J@"N/$YE1P_NQ]Z M7E_F-1;/@S]GO_@F7XK\<_9M7^(=P_A+16PXTZ/#7TR^_58@>.N3["OT;^$_ MP/\ !/P2T4:9X/T*WTN,C][< ;YYCZR2'YF/U-=W17RF(QM;$OWWIVZ&J204 M445PC"BBB@ HHHH SO$5C+J>@ZA:0[?.G@>--QP,D$#-9/P]\.W7AG19;6[V M>8TYD&QLC!51_,&NGHH @OK*+4;.:UG7?#*I1USC(-<'-\(8EE/V75;B"!CE MHSSWZ<$9_&O0Z* ,?PSX7L_"MB;>T#,6.7D?[S&MBBB@#B]4^&\=UK3ZE97\ MVGRR',BQY[]<$$8S5C0_AW9Z!K$>H07,TD@3:PE()8XP6)]ZZRB@ KRWXD:> MNJ>.='M7=XUECC0O'PRY=^1[UZE4;6\4DBNT:,Z]&*@D?C3 XRU^&43:I'>: MEJ$^I>208XY"<<=,Y)KMZ**0%'6-'MM=T^6SNTWQ/^8/8CWKD(_A:\3G%:U%% !1110!S/BCP)9>)IEN& MEDMKI0!YD9ZXSC(_&LO2?A7;6MY'<7][-J!C.51\[?QR37=44 )TX'2J.MZ+ M:^(-.DLKM-T3\@CJI'0CWJ_10!P5O\*_+1;:36+I]/5MRVXX_KC]*[J&)8(4 MC7.U%"C)R<"GT4 8GBOPQ'XJL8;:69H5CE$H*C.< C'ZUIZ?9C3]/MK56+K! M$L08]3M &?TJQ10!!>V<.H6LMM<()(9%VLI[BN)7X6_9VDBM=8NH+*0Y:%2? MRX('Z5WM% &?H6BP^']-CLX&=T4Y+2'))/4^WX5:O+<7EG/;DE1+&T98=LC& M:FHH PO"?A6+PK;W,44S3">7S26&,'&,5#X7\%P^%[R^N(KAYFNCE@P QR3_ M %KHZ* "N2\0_#VWUC5!J5K\ MGO;R9=KR2,<8Z]/P[UT-%% '(:Y\.K?4-4;4;*[ETV\8Y9HNA/KP00?QJWX; M\%QZ#=O>27D]Y=NI5GD8XYZ\=^@ZUTE% !7-1>"HHO%DFM_:I2[<^5VSC&,^ MGM72T4 %%%% !7.>*O ]GXJ>.:622"YC&U9(SU R0"/J:Z.B@#@=/^$MM'=1 M3:C?3:@L9RL;9"GV.23BN]'' X%+10!F^(-"M_$>ERV-SN$;X(9?O*1R"*Y. M'X41-:FVN]4N;BV4'RH@2%3/?!)Z5WU% &;X=T5/#^DQ6,*V+222',DK]6]O85L10QP+MCC6->N% I], KE/$7 MP_M=:U#^T+>XEL+[O)$>"1T/U^E=712 Y;P_X'71]0.H7-_<7UY@C<[''/XD M_K74T44 8-]X4BOO%%GK1G=9+= @B &#C=W_ .!?I6]110!'<0BXMY(B%;.:WBF:82/ORPQC@#^E;E% !7&ZI\.(;C4I-0TZ]FTRYD.6 M\HG;SUZ$$9KLJ* .9\+^!;/PW<27?FR7E])P9Y>HSUQ]?>NFHHH Y_4O"$6I M>([35VG9)+<*!& ,'!/^-=!110 4444 %'-7O;^.X>5[H$,K #+ M;JZ6B@#E]?\ EOK6K1:G%+ 08X]Q XZ#DG],5VU% M!6%XF\+#Q"UO(M[<6<]ODQM$W&3W(_#J*W:* .4T7P&EAJRZI?7TVI7RC"O* M3A>,9Y)[9KJZ** .9\7^![;Q6T$QF>UNX>$F3TSG!^AYK(N/A/;WRK)=:E=3 MW@/,SG(QC& #^?6N]HI@%8OBGPS'XHLX;>69H1'*)05&%O!MM MX9:>999+J[N#F2:4\^N!^-=!10 5S&D^!H=+UZ^U,7^,< M5T]% !7QA^U=_P E;7_KR@_FU?9]?&'[5W_)6U_Z\H/YM7UO#'^__P#;K_0_ M/^./^13_ -O+]3X?_;D_Y+D/^P'IG_I*E>$Z/_R%K+_KNG_H0KW;]N3_ )+D M/^P'IG_I*E>$Z/\ \A:R_P"NZ?\ H0KW:?\ #1]AAOX,/1?D?T)^&_\ D7=+ M_P"O6+_T 5I5F^&_^1=TO_KUB_\ 0!6E7YL]ST HHHI %%%% 'DGQP_9;^'O M[0%BR>)M%1=4"%8=8LL17<7!Q\X'S 9SM<$>U<7\"/V#?AG\#[B/4A9-XH\0 MQMN34M857\GD$>7&!M4C'WL%N3SVKZ/HKH6(K1A[-2=A6$ P, 8%+117.,** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^,/VKO^2MK_UY M0?S:OL^OC#]J[_DK:_\ 7E!_-J^MX8_W_P#[=?Z'Y_QQ_P BG_MY?J?#_P"W M)_R7(?\ 8#TS_P!)4KPG1_\ D+67_7=/_0A7NW[[3_AH^PPW\&'HOR/Z$_#?_(NZ7_UZQ?^@"M*LWPW_P B[I?_ M %ZQ?^@"M*OS9[GH!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH *^,/VKO^2MK_UY0?S:OL^OC#]J[_DK:_\ M7E!_-J^MX8_W_P#[=?Z'Y_QQ_P BG_MY?J?#_P"W)_R7(?\ 8#TS_P!)4KPG M1_\ D+67_7=/_0A7NW[[3_AH^PP MW\&'HOR/Z$_#?_(NZ7_UZQ?^@"M*LWPW_P B[I?_ %ZQ?^@"M*OS9[GH!111 M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *^,/VKO^2MK_UY0?S:OL^OCG]K33;FW^)UK>20LMK<6<:Q2X^5BK,& M'U&1^8KZSAAI8_7^5_H? <;IO*6TMI+]3X6_;D_Y+D/^P'IG_I*E>$Z/_P A M:R_Z[I_Z$*]V_;D_Y+D/^P'IG_I*E>$Z/_R%K+_KNG_H0KWJ?\-'U^&_@P]% M^1_0GX;_ .1=TO\ Z]8O_0!6E6;X;_Y%W2_^O6+_ - %:5?FSW/0"BBBD 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 5QWQ4^'EI\2?"=QILRJMU'^]M)C_RSE X_ ]#[&NQHK6C5G0J1JTW9K5'/ MB*%/%4I4*RO&2LT?BU^WMI=UHWQ_DM+R%H9H]&T]"&'!*VZJ2#W&Y2,CT-?/ M^C_\A:R_Z[I_Z$*_8W]N#]E>#]H;P ;_ $F%8_&NBQM)82 &YCZM;L?0]5] M&]B:_'>SM)]/\006MS#);W,-TL2T\?\ ;]I"F0AW "Z '8\!OP;U MK]%JJ:M;Q7>EW<,\230R1,KQR*&5A@\$'K77A<1/#U%.(FKD'AO_ )%W2_\ MKUB_] %:54M%4)H]@J@*H@C ' ^45=KE>XPHHHI %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% D% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9 end GRAPHIC 5 exh991large_1.jpg begin 644 exh991large_1.jpg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gnw-20190101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 7 gnw-20190101_def.xml XBRL DEFINITION FILE EX-101.LAB 8 gnw-20190101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 9 gnw-20190101_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 27, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 27, 2023
Entity File Number 1-13738
Entity Registrant Name PSYCHEMEDICS CORPORATION
Entity Central Index Key 0000806517
Entity Tax Identification Number 58-1701987
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 289 Great Road
Entity Address, City or Town Acton
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01720
City Area Code 978
Local Phone Number 206-8220
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock. $0.005 par value
Trading Symbol PMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 11 f8k_112723_htm.xml IDEA: XBRL DOCUMENT 0000806517 2023-11-27 2023-11-27 iso4217:USD shares iso4217:USD shares 0000806517 false 8-K 2023-11-27 PSYCHEMEDICS CORPORATION DE 1-13738 58-1701987 289 Great Road Acton MA 01720 978 206-8220 false false false false Common stock. $0.005 par value PMD NASDAQ false EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globenewswire.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_112723.htm gnw-20190101.xsd gnw-20190101_def.xml gnw-20190101_lab.xml gnw-20190101_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "f8k_112723.htm": { "nsprefix": "gnw", "nsuri": "http://globenewswire.com/20190101", "dts": { "inline": { "local": [ "f8k_112723.htm" ] }, "schema": { "local": [ "gnw-20190101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "gnw-20190101_def.xml" ] }, "labelLink": { "local": [ "gnw-20190101_lab.xml" ] }, "presentationLink": { "local": [ "gnw-20190101_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://globenewswire.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Form8K", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "f8k_112723.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Form8K", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "f8k_112723.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://globenewswire.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 18 0001171843-23-007278-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-23-007278-xbrl.zip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